Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Levonorgestrel
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Approved
Sponsor : Aurobindo Pharma Limited
Deal Size : Not Applicable
Deal Type : Not Applicable
New Healthcare Brand Launches Nationwide
Details : Julie emergency contraception offers Levonorgestrel 1.5mg, an FDA-approved, progestin-only emergency contraceptive that helps prevent pregnancy by temporarily delaying or stopping ovulation.
Brand Name : Julie
Molecule Type : Small molecule
Upfront Cash : Not Applicable
September 28, 2022
Lead Product(s) : Levonorgestrel
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Approved
Sponsor : Aurobindo Pharma Limited
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?